Akili Interactive Labs
Boston
About Akili Interactive Labs
Akili Interactive Labs their broad pipeline of programs to treat cognitive deficiency and improve symptoms associated with medical conditions across neurology and psychiatry, including attention-deficit hyperactivity and disorder (ADHD), major depressive disorder (MDD), autism spectrum disorder (ASD) and various inflammatory diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $270.6M
- Funding stage: M&A
- Last round: Series D (May 2021)
- Ticker: nasdaq:AKLI
- Website: akiliinteractive.com
- Phone: +1 415-419-5503
Industries & Categories
Biotechnology, Health Care, Medical, Neuroscience, Service Industry
Social Profiles
Canonical: https://fsome.com/organization/akili-interactive-labs-79394 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.